Many surgeons reported treating women with variant of uncertain significance the same as women with pathogenic mutations, in spite of current guidelines.
Undiagnosed Disease Network researchers used exome sequencing to diagnose more than one-quarter of individuals previously denied clinical exome reimbursement.
Eleven new studies from the NHLBI NextGen Consortium show different uses for iPSCs to study polygenetic diseases across various systems in the human body.
The funding will be used to develop new software and data structures to enable researchers to use the GO data for network-based analysis.
In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.
Stanford's John Ioannidis and his team report on sources of bias in the scientific literature.
The gene-gene interactions research could lead to new therapies targeting cells with particular mutations, or combinations of targeted therapies.
Funded by a $600 million gift, the Biohub will support investigators at three universities as well as two initial internal projects.
The organizations will each contribute expertise in immunotherapy and epigenomics to improve cancer treatment options for patients.
In Cell this week: essential genes in AML, indel hotspots affect certain genes in cancer, and more.
Dog DNA testing finds that some purebreds might not truly be purebreds, Inside Edition reports.
Mary Beckerle has returned as director of the Huntsman Cancer Institute, according to ScienceInsider.
Smithsonian Magazine reports that environmental DNA sampling can be used to track elusive organisms.
In Genome Research this week: repetitive satellite DNA in the fruit fly, transcriptome map assembly pipeline, and more.